Across the recent three months, 15 analysts have shared their insights on Legend Biotech (NASDAQ:LEGN), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 9 | 6 | 0 | 0 | 0 |
| Last 30D | 1 | 2 | 0 | 0 | 0 |
| 1M Ago | 2 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 3 | 0 | 0 | 0 |
| 3M Ago | 4 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $76.73, a high estimate of $90.00, and a low estimate of $60.00. A decline of 1.15% from the prior average price target is evident in the current average.
Exploring Analyst Ratings: An In-Depth Overview
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in